Header Logo

Zoe Arvanitakis

Concepts (73)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cognition
3
2024
220
0.860
 Why?
Insulin-Like Growth Factor I
1
2024
18
0.800
 Why?
Cardiovascular Diseases
1
2024
44
0.780
 Why?
Biomarkers
1
2024
101
0.780
 Why?
Neuropathology
1
2018
16
0.540
 Why?
Dementia
2
2018
73
0.540
 Why?
Memory Disorders
1
2018
33
0.530
 Why?
Aged
8
2025
956
0.450
 Why?
Neuropsychological Tests
4
2024
238
0.410
 Why?
Female
9
2025
1724
0.400
 Why?
Alzheimer Disease
4
2025
250
0.370
 Why?
Apolipoprotein E4
3
2025
76
0.350
 Why?
Humans
9
2025
2957
0.320
 Why?
Cognitive Dysfunction
2
2024
165
0.280
 Why?
Male
8
2025
1860
0.250
 Why?
Aging
3
2018
204
0.250
 Why?
Risk Factors
3
2024
275
0.230
 Why?
Middle Aged
3
2024
792
0.220
 Why?
ATP Binding Cassette Transporter 1
1
2025
3
0.220
 Why?
Lysosomes
1
2025
5
0.220
 Why?
Cellular Senescence
1
2025
7
0.220
 Why?
Cholesterol
1
2025
18
0.220
 Why?
Aged, 80 and over
5
2018
567
0.210
 Why?
Brain-Derived Neurotrophic Factor
1
2024
12
0.200
 Why?
Vascular Endothelial Growth Factor A
1
2024
18
0.200
 Why?
Cross-Sectional Studies
1
2024
105
0.200
 Why?
Incidence
3
2018
110
0.180
 Why?
Cognition Disorders
2
2018
175
0.180
 Why?
Mental Status Schedule
2
2018
29
0.170
 Why?
Cohort Studies
2
2018
233
0.160
 Why?
Community Health Planning
1
2018
5
0.140
 Why?
Brain Infarction
1
2018
20
0.140
 Why?
Independent Living
1
2018
29
0.140
 Why?
Ambulatory Care
1
2017
9
0.130
 Why?
Chronic Disease
1
2017
28
0.130
 Why?
Hospitalization
1
2017
49
0.130
 Why?
Neoplasms
1
2017
18
0.120
 Why?
Diabetes Complications
1
2016
10
0.120
 Why?
Diabetes Mellitus, Type 2
1
2016
28
0.120
 Why?
Cerebral Amyloid Angiopathy
1
2015
17
0.110
 Why?
Longitudinal Studies
3
2017
260
0.090
 Why?
Brain
2
2025
202
0.080
 Why?
Chicago
2
2017
160
0.060
 Why?
Follow-Up Studies
2
2017
147
0.060
 Why?
Risk Assessment
1
2006
51
0.060
 Why?
Mice, Knockout
1
2025
67
0.050
 Why?
Mice
1
2025
343
0.050
 Why?
Animals
1
2025
1050
0.040
 Why?
Memory
1
2018
48
0.030
 Why?
Likelihood Functions
1
2017
9
0.030
 Why?
Odds Ratio
1
2017
32
0.030
 Why?
Plaque, Amyloid
1
2017
18
0.030
 Why?
Neurofibrillary Tangles
1
2017
24
0.030
 Why?
tau Proteins
1
2017
18
0.030
 Why?
Hypoglycemic Agents
1
2016
11
0.030
 Why?
Linear Models
1
2016
39
0.030
 Why?
Disease Progression
1
2016
99
0.030
 Why?
Time Factors
1
2016
208
0.030
 Why?
Prospective Studies
1
2016
203
0.030
 Why?
Genetic Association Studies
1
2015
24
0.030
 Why?
Logistic Models
1
2015
60
0.030
 Why?
Genotype
1
2015
85
0.030
 Why?
Alleles
1
2015
65
0.030
 Why?
Heterozygote
1
2015
48
0.030
 Why?
Severity of Illness Index
1
2015
97
0.030
 Why?
Bias
1
2006
6
0.020
 Why?
Statistics as Topic
1
2006
19
0.020
 Why?
Community Health Services
1
2006
8
0.020
 Why?
Comorbidity
1
2006
49
0.020
 Why?
Reproducibility of Results
1
2006
83
0.010
 Why?
Age Factors
1
2006
89
0.010
 Why?
Sensitivity and Specificity
1
2006
74
0.010
 Why?
United States
1
2006
243
0.010
 Why?
Arvanitakis's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (73)
Explore
_
Co-Authors (27)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_